ICD-10-CM Billable Code

C44.1122

Basal cell carcinoma of skin of right lower eyelid, including canthus

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) is a common type of skin cancer that frequently affects sun-exposed areas of the skin. When it appears on the right lower eyelid, including the canthus (corner of the eye), it can involve delicate tissues around the eye. BCC grows slowly and rarely spreads to other parts of the body, but if left untreated, it can cause local destruction and disfigurement. Recognizing and understanding this condition is crucial for effective management and treatment.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds Fair skin that is more susceptible to sunlight damage History of frequent sunburns or excessive sun exposure Age, with increased risk as individuals grow older Previous skin cancers or genetic conditions that predispose to skin tumors Immunosuppression or weakened immune system

Key Symptoms: A small, shiny or translucent bump on the eyelid A sore that does not heal or heals and then recurs A raised or pearly lesion with or without visible blood vessels A scar-like area that appears slightly indented or with rolled edges Changes in the skin texture or color around the eyelid Occasional bleeding or crusting from the lesion

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a thorough examination by a healthcare professional, who assesses the visible lesion and its characteristics. A biopsy, where a small tissue sample is taken and examined under a microscope, is essential to confirm the presence of basal cell carcinoma. Additional imaging studies may be performed if the tumor appears to invade deeper tissues or surrounding structures.

Treatment Protocols: Surgical excision: Removing the tumor along with some healthy surrounding tissue to ensure complete removal. Mohs micrographic surgery: A precise technique that removes the cancer layer by layer, examining each layer immediately until no cancer cells remain, preserving as much healthy tissue as possible. Radiation therapy: Used when surgery is not feasible or as an adjunct treatment, especially for tumors in difficult locations. Topical treatments: Such as imiquimod cream or fluorouracil cream for superficial types, although less common for eyelid involvement. Photodynamic therapy: Uses special light and a photosensitizing agent to destroy cancer cells in selected cases. Reconstructive procedures: After tumor removal, reconstructive surgery may be necessary to restore eyelid function and appearance.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.1122 a billable ICD-10 code?
Yes, C44.1122 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.1122?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of right lower eyelid, including canthus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference